Table 3: Variables with significant variation by sex, age, and diagnosis delay.
Number (%) | OR [CI 95%] | p-value (X2) | ||
Significant variations by gender | ||||
Oculomotor palsy | Women | 12 (28.9) | 10.16 [1.2-82.9] | 0.008 (6.52) |
Men | 1 (3.8) | |||
Pathological brain imaging | Women | 28 (62.2) | 3.11 [1.13-8.52] | 0.01 (5.03) |
Men | 9 (34.6) | |||
Tuberculomas | Women | 18 (40.0) | 5.11 [1.3-19.6] | 0.009 (6.40) |
Men | 3 (11.5) | |||
Significant variations by age | ||||
Glasgow score < 10 | Age < 65 years | 3 (5.0) | 10.7 [1.9-57.8] | 0.009 (10.1) |
Age ≥ 65 years | 5 (45.5) | |||
Mortality | Age < 65 years | 1 (1.7) | 0.03 [0.003-0.3] | 0.001 (15.2) |
Age ≥ 65 years | 4 (33.3) | |||
Pathological brain imaging | Age < 65 years | 34 (57.6) | 4.08 [1.001-16.62] | 0.04 (4.2) |
Age ≥ 65 years | 3 (25) | |||
Significant variations by delay diagnosis | ||||
Tuberculomas | ≤ 30 days | 11 (23.9) | 0.3 [0.1-0.9] | 0.03 (4.4) |
> 30 days | 10 (50.0) | |||
Hydrocéphalus | ≤ 30 days | 3 (6.5) | 0.13 [0.03-0.57] | 0.006 (8.8) |
> 30 days | 7 (35.0) | |||
Low glucose levels in CSF | ≤ 30 days | 26 (61.5) | 0.2 [0.04-0.99] | 0.03 (4.4) |
> 30 days | 18 (88.9) |